510(k) Report

510(k) · Cleared

Cleared

EndoFLIP® System with FLIP Topography module

K170833510(k) SpecialCleared Apr 17, 201728-day reviewClass II21 CFR 876.1725

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Crospon, Ltd. · FFX System, Gastrointestinal Motility (Electrical)

Cleared on Apr 17, 2017 as substantially equivalent to K160725 (Crospon, Ltd., 2016) after a 28-day review. Its family tree reaches back 4 generations to 1999.

Decided
Apr 17, 2017
Review
28 days
Class
Class II
Product code
FFX
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K991288 (1999). 5 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK991288 Distender Series II BarostatG & J Electronics, Inc. · 1999
  2. 3 generations backK092850 EndoflipCrospon, Ltd. · 2009
  3. 2 generations backK120997 Barostat Software OptionCrospon, Ltd. · 2012
  4. 1 generation backK160725 EndoFLIPCrospon, Ltd. · 2016
  5. This deviceK170833 EndoFLIP® System with FLIP Topography moduleCrospon, Ltd. · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K991288Distender Series II BarostatG & J Electronics, Inc.1999—
−3K092850EndoflipCrospon, Ltd.2009—
−2K120997Barostat Software OptionCrospon, Ltd.2012—
−1K160725EndoFLIPCrospon, Ltd.2016—
0 (this device)K170833EndoFLIP® System with FLIP Topography moduleCrospon, Ltd.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210
FIG. 1 — Lineage of K170833, 1999–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FFX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FFX device

  1. #1 K262621 Rapid Barostat Bag (RBB) Pump and Catheter…score 12.4 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K160725EndoFLIP
Summary page 4
…onitoring system Classification Name: FFX Device: FLIP Topography module Modified Device: K160725 – EndoFLIP® System – Crospon Ltd. Device Description: The modification to the EndoFLIP® System is the addition of display functi…
Crospon, Ltd.2016—
†K120997Barostat Software OptionCrospon, Ltd.2012—
†K092850EndoflipCrospon, Ltd.2009—

Also cleared against K160725: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 2 companies; a new generation was cleared every 3.7 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • 1 other device also cites its predicate K160725.

How does its category compare?

All FFX devices

FFX System, Gastrointestinal Motility (Electrical): FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · FFX

1in 2025

2007: 22008: 12009: 22010: 22012: 42013: 12016: 32017: 22018: 12019: 42020: 12023: 32024: 12025: 12026 (partial year): 1
2007high 4 (2012) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FFX

123in 2023

2012: 120 days median2016: 145 days median2019: 240 days median2023: 123 days median
2007high 240 (2019) · low 120 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FFX

2so far in 2026, the most since 2007

2009: 12011: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FFX

32in 2025

2009: 22010: 62011: 62012: 42013: 42014: 42015: 102016: 152017: 102018: 172019: 272020: 202021: 262022: 312023: 512024: 592025: 32
2007high 59 (2024) · low 0 (2007)2025

MAUDE reports naming product code FFX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
20092—12
20102—06
20110—16
2012412004
20131—04
20140—04
20150—010
20163145015
20172—010
20181—017
20194240027
20201—020
20210—026
20220—031
20233123051
20241—059
20251—032
20261—2—

What is it indicated for?

The EndoFLIP® System is indicated for use in a clinical setting to measure pressure and dimensions in the esophagus, pylorus, and anal sphincters. It is intended to be used as an adjunct to other diagnostic methods as part of a comprehensive evaluation of patients with symptoms consistent with gastrointestinal motility disorders. The EF-325 series of catheters can make pressure and dimensional measurements in the esophagus, pylorus, and anal sphincters…

Read the full statement (153 words)

The EndoFLIP® System is indicated for use in a clinical setting to measure pressure and dimensions in the esophagus, pylorus, and anal sphincters. It is intended to be used as an adjunct to other diagnostic methods as part of a comprehensive evaluation of patients with symptoms consistent with gastrointestinal motility disorders.

The EF-325 series of catheters can make pressure and dimensional measurements in the esophagus, pylorus, and anal sphincters; whereas the BF-325 series and EF-825 catheters can make dimensional measurements in the esophagus, pylorus, and anal sphincters. The EF-620 catheter can make dimensional measurements in the esophagus.

Other indications for use include:

• To estimate the size of a stoma produced by a gastric band (all EndoFLIP® catheters)

• For use as an adjunct to a bougie for measuring the size of a gastric sleeve created during bariatric surgery, where it is suitable for diameter measurements for 22 to 60Fr sleeves (EF-620 catheter)

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K170833: EndoFLIP® System with FLIP Topography module.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K170833

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026